Keymed Biosciences Inc. (2162.HK)
HKD 33.0
(-1.93%)
HKD 33.0
(-1.93%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.37 CNY | -16.1% |
| 2022 | -1.18 CNY | 95.13% |
| 2021 | -24.24 CNY | -689.58% |
| 2020 | -3.07 CNY | -379.69% |
| 2019 | -0.64 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.64 CNY | 17.95% |
| 2024 Q2 | -0.64 CNY | 0.0% |
| 2023 Q3 | -0.78 CNY | -967.63% |
| 2023 FY | - CNY | -16.1% |
| 2023 Q4 | -0.78 CNY | 0.0% |
| 2023 Q1 | 0.09 CNY | 114.98% |
| 2023 Q2 | 0.09 CNY | 0.0% |
| 2022 Q2 | 0.01 CNY | 0.0% |
| 2022 FY | - CNY | 95.13% |
| 2022 Q1 | 0.01 CNY | 102.0% |
| 2022 Q4 | -0.60 CNY | 0.0% |
| 2022 Q3 | -0.60 CNY | -5982.35% |
| 2021 FY | - CNY | -689.58% |
| 2021 Q4 | -0.51 CNY | 0.0% |
| 2021 Q3 | -0.51 CNY | 98.11% |
| 2021 Q2 | -27.04 CNY | 0.0% |
| 2021 Q1 | -27.04 CNY | -363.01% |
| 2020 Q4 | -5.84 CNY | 0.0% |
| 2020 FY | - CNY | -379.69% |
| 2020 Q2 | -0.26 CNY | 0.0% |
| 2020 Q3 | -5.84 CNY | -2146.15% |
| 2020 Q1 | -0.26 CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | 12442.342% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 76211.111% |